TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PharmaFocus AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,586
|
1,475
|
1,457 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
409
|
269
|
348 |
EBITDA |
383
|
325
|
406 |
Total assets |
2,358
|
2,339
|
2,360 |
Current assets |
2,358
|
2,339
|
2,290 |
Current liabilities |
238
|
300
|
280 |
Equity capital |
1,958
|
1,881
|
1,906 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
83.0%
|
80.4%
|
80.8% |
Turnover per employee |
1,586
|
1,475
|
1,457 |
Profit as a percentage of turnover |
25.8%
|
18.2%
|
23.9% |
Return on assets (ROA) |
17.4%
|
11.5%
|
14.7% |
Current ratio |
990.8%
|
779.7%
|
817.9% |
Return on equity (ROE) |
20.9%
|
14.3%
|
18.3% |
Change turnover |
111
|
18
|
26 |
Change turnover % |
8%
|
1%
|
2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.